News

Post-PCV13 findings prompt continued surveillance


 

References

Additionally, subdural empyema on neuroimaging increased from 1% to 16%, but was not associated with any particular serotype and was not associated with the cases of hemiparesis.

Overall, 52% of survivors had some sort of neurologic sequelae at the time of discharge, but there were no differences in terms of specific sequelae between the two groups.

The rates of morbidity and mortality for pneumococcal meningitis remain substantial and have not changed significantly since introduction of PCV13, Dr. Olarte said.

However, if the number of cephalosporin nonsusceptible pneumococci isolated from children with meningitis continues to decrease, modification of empiric antibiotic selection for suspected bacterial meningitis might be considered in the future, therefore ongoing surveillance is warranted, she said.

The studies were partially supported by Pfizer. The authors reported having no other disclosures.

Pages

Recommended Reading

Clinical trial begins for new Ebola vaccine
MDedge Family Medicine
Short-course TB therapy fails in three international trials
MDedge Family Medicine
Nigeria and Senegal now free of Ebola, averting potential urban crisis
MDedge Family Medicine
Careful exam distinguishes molluscum from lookalikes
MDedge Family Medicine
CDC confirms Ebola case in New York City
MDedge Family Medicine
DeSalvo leaves post to focus on Ebola response
MDedge Family Medicine
Dallas nurse Ebola free, discharged from NIH hospital
MDedge Family Medicine
Guidelines for children’s bronchiolitis treatment issued by AAP
MDedge Family Medicine
House panel faults CDC’s Ebola response
MDedge Family Medicine
Consider strep, not MRSA, when eczematous children suffer skin infections
MDedge Family Medicine